Journal article

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer

Fabio Y Moraes, Luke A Perry, Jahan C Penny-Dimri, Dhruvesh Ramson, Tiago B de Castria, Rayleen V Bowman, Fábio N Santos, Kwun M Fong, Rachel Riera

Cochrane Database of Systematic Reviews | Wiley

University of Melbourne Researchers